eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Share:
Share:
Review paper

Trichological disorders in organ transplant recipients (OTRs): a literature review

Ewa Pasierbska
1, 2
,
Alicja Dębska-Ślizień
3
,
Beata Imko-Walczuk
1

  1. Dermatology and Venereology Clinic, COPERNICUS, Independent Public Healthcare Centre, Gdansk, Poland
  2. Dermatology Department, Provincial Hospital, Elblag, Poland
  3. Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdansk, Poland
Adv Dermatol Allergol
Online publish date: 2025/02/05
Article file
- Trichological.pdf  [0.13 MB]
Get citation
 
 
1. Overbeck I, Bartels M, Decker O, et al. Changes in quality of life after renal transplantation. Transplant Proc 2005; 37: 1618-21.
2. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-30.
3. Peters TG, Spinola KN, West JC, et al. Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects. Transplantation 2004; 78: 537-43.
4. Ho CH, Sood T, Zito PM. Androgenetic alopecia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 7, 2024.
5. Hughes EC, Syed HA, Saleh D. Telogen effluvium. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 1, 2024.
6. Saleh D, Nassereddin A, Saleh HM, et al. Anagen effluvium. In: StatPearls. Treasure Island (FL): StatPearls Publishing; April 30, 2024.
7. Hordinsky MK. Overview of alopecia areata. J Investig Dermatol Symp Proc 2013; 16: S13-5.
8. Tricot L, Lebbé C, Pillebout E, et al. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation 2005; 80: 1546e9.
9. Imko-Walczuk B, Okuniewska A, Prêdota-G³owacka A, et al. Benign cutaneous disease among Polish renal transplant recipients. Transplant Proc 2016; 48: 1660-6.
10. Bencini PL, Montagnino G, Sala F, et al. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica 1986; 172: 24-30.
11. Busque S, Demers P, St-Louis G, et al. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. Transplant Proc 1998; 30: 1247-8.
12. Prakash J, Singh S, Prashant GK, et al. Mucocutaneous lesions in transplant recipient in a tropical country. Transplant Proc 2004; 36: 2162-4.
13. Videla CO. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy. Transplant Proc 2009; 41: 2659-63.
14. Rostaing L, Sánchez-Fructuoso A, Franco A, et al. Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study. Transpl Int 2012; 25: 391-400.
15. Usuki S, Uno S, Sugamori H, et al. Safety and effectiveness of conversion from cyclosporine to once-daily prolonged-release tacrolimus in stable kidney transplant patients: a multicenter observational study in Japan. Transplant Proc 2018; 50: 3266-74.
16. Ringdén O, Bergstrand A, Collste H, et al. Immunosuppression by cyclosporin A in human renal transplant recipients. Scand J Urol Nephrol Suppl 1981; 64: 220-9.
17. Hequet O, Vocanson M, Saint-Mezard P, et al. CD4 T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease. Am J Transplant 2004; 4: 872-8.
18. Shapiro R, Fung JJ, Jain AB, et al. The side effects of FK 506 in humans. Transplant Proc 1990; 22: 35-6.
19. Peters TG, Spinola KN, West JC, et al. Differences in patient and transplant professional perceptions of immunosuppression-induced cosmetic side effects. Transplantation 2004; 78: 537-43.
20. Kim HC, Hwang EA, Han SY, et al. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center. Transplant Proc 2004; 36: 2082-3.
21. Meera M, Manikandan S, Parameswaran S. Adverse effects of tacrolimus and its associated risk factors in renal transplant recipients. Exp Clin Transplant 2023; 21: 22-7.
22. Lee EC, Kim SH, Park SJ. Safety and efficacy of once-daily prolonged-release tacrolimus in living donor liver transplantation: an open-label, prospective, single-arm, phase 4 study. Ann Transplant 2018; 23: 713-20.
23. Alatas FS, Matsuura T, Yoshimaru K, et al.. Alopecia in children following living related liver transplantation. Transplant Proc 2021; 53: 228-32.
24. Talbot T, Rix D, Abusin K, et al. Alopecia as a consequences of tacrolimus therapy in renal transplantation. Transplantation 1997; 64: 1631e2.
25. Hawkshaw NJ, Haslam IS, Ansell DM, et al. Re-evaluating cyclosporine a as a hair growth-promoting agent in human scalp hair follicles. J Invest Dermatol 2015; 135: 2129-32.
26. Ponticelli C, Bencini PL. Nonneoplastic mucocutaneous lesions in organ transplant recipients. Transpl Int 2011; 24: 1041-50.
27. Higgins RM, Hart P, Lam FT, et al. Conversion from tacrolimus to cyclosporin in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. Transplantation 2000; 70: 199-202.
28. Mohsin N, Pakkyara A, Budruddin M, et al. Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics? Transplant Proc 2005; 37: 2911-2.
29. Phillips MA, Graves JE, Nunley JR. Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine. J Am Acad Dermatol 2005; 53 (5 Suppl 1): S252-5.
30. Mártinez JM, Pulido LB, Bellido CB, et al. Rescue immunosuppression with mammalian target of rapamycin inhibitor drugs in liver transplantation. Transplant Proc 2010; 42: 641-3.
31. Murray JE, Merrill JP, Harrison JH, et al. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 1963; 268: 1315-23.
32. Shah S, Verma P. Overview of pregnancy in renal transplant patients. Int J Nephrol 2016; 2016: 4539342.
33. Saida K, Kamei K, Ogura M, et al. Azathioprine-induced agranulocytosis and severe alopecia after kidney transplantation associated with a NUDT15 polymorphism: a case report. Transplant Proc 2018; 50: 3925-7.
34. Wagoner LE, Olsen SL, Bristow MR, et al. Cyclophosphamide as an alternative to azathioprine in cardiac transplant recipients with suspected azathioprine-induced hepatotoxicity. Transplantation 1993; 56: 1415-8.
35. Palmer SC, Tunnicliffe DJ, Singh-Grewal D, et al. Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: a network meta-analysis of randomized trials. Am J Kidney Dis 2017; 70: 324-36.
36. Castello M, Gregorini M, Rampino T, et al. A retrospective analysis of dermatological lesions in kidney transplant patients. Indian J Med Res 2013; 137: 1188-92.
37. Miotto IZ, Souza BCE, Tyring SK, et al. Immunosuppressant-induced cutaneous drug reactions in solid organ transplant recipients. Transpl Immunol 2021; 64: 101355.
38. Matas AJ, Halbert RJ, Barr ML, et al. Life satisfaction and adverse effects in renal transplant recipients: a longitudinal analysis. Clin Transplant 2002; 16: 113-21.
39. Ito T. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol 2013; 2013: 348546.
Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.